Lipid-lowering therapy and the risk of dementia: lessons learned from two decades of controversy

Eur Heart J. 2023 Jun 1;44(21):1855-1857. doi: 10.1093/eurheartj/ehad103.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dementia*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
  • Lipids

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids